SEO URLwww.firestrike.ai/deals/bayer-zuellig-pharma-acquisition-2026
acquisitionAnnounced · Feb 9, 2026HealthcareSource · CredibleArticle · Factual
Zuellig Pharma acquires BAYER
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
BAYER
FRA: BAYN · Leverkusen, Nordrhein-Westfalen
Acquirer
Zuellig Pharma
Full Acquisition
Status
Announced
Zuellig Pharma agreed to acquire BAYER. Reported deal value: Undisclosed. Status: Announced. Sector: Healthcare. Target headquarters context: Leverkusen, Nordrhein-Westfalen, Germany.
This page summarizes publicly available information about the transaction as of 2026-02-09. Figures and status may change as filings and press coverage update.
Zuellig Pharma , a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to the Zam-Buk ® consumer healthcare brands from Bayer Consumer Care AG for Thailand, Singapore , Indonesia, Malaysia and Brunei
Deal timeline
Announced
Feb 9, 2026 · vir.com.vn
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Healthcare. Figures and status may change as sources update.
Sources: vir.com.vn · Primary article · FireStrike proprietary index